VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,127,679 | -4.0% | 264,871 | +7.4% | 0.07% | -5.4% |
| Q2 2023 | $7,422,416 | +5.5% | 246,510 | +13.4% | 0.07% | -2.6% |
| Q1 2023 | $7,035,187 | +11.5% | 217,471 | -1.2% | 0.08% | +35.7% |
| Q4 2022 | $6,309,413 | -99.9% | 220,147 | -58.2% | 0.06% | -17.6% |
| Q3 2022 | $6,357,351,000 | +109717.8% | 526,622 | +149.1% | 0.07% | +15.3% |
| Q2 2022 | $5,789,000 | -28.9% | 211,444 | -0.4% | 0.06% | -30.6% |
| Q1 2022 | $8,141,000 | +40.8% | 212,274 | +17.6% | 0.08% | +44.1% |
| Q4 2021 | $5,783,000 | -7.4% | 180,558 | -14.8% | 0.06% | -4.8% |
| Q3 2021 | $6,242,000 | -20.7% | 211,800 | -8.6% | 0.06% | -30.3% |
| Q2 2021 | $7,874,000 | -4.4% | 231,738 | -8.6% | 0.09% | -15.2% |
| Q1 2021 | $8,238,000 | -25.3% | 253,471 | -16.0% | 0.10% | -18.0% |
| Q4 2020 | $11,032,000 | -99.8% | 301,740 | +72.2% | 0.13% | -0.8% |
| Q3 2020 | $6,911,000,000 | – | 175,256 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |